- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01258621
Learning Curve for Laparoscopic Distal Pancreatectomy
December 10, 2010 updated by: Università Vita-Salute San Raffaele
Learning Curve for Laparoscopic Distal Pancreatectomy in a High-volume Hospital
Laparoscopic distal pancreatectomy (LDP) for benign and borderline pancreatic lesions has recently becoming the treatment of choice in experienced centres.
No data have been published about learning curve so far.
The purpose of this study was to identify the learning curve period for performing LDP.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Between March 2009 and August 2010 all patients with lesion of body or tail of pancreas were assessed for eligibility for LDP.
Exclusion criteria were: major vessels contact in cancer patients, severe organ dysfunction, BMI > 35, and refusing laparoscopic approach.
All laparoscopic procedures were carried out by the same surgical team with large experience in open pancreatic surgery.
All patients were treated according to an early recovery after surgery protocol.
Primary endpoint was conversion rate.
Secondary endpoints were operation time, operative blood loss, postoperative morbidity, and length of stay.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Milan, Italy, 20132
- San Raffaele Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- pancreatic lesion located at body or tail
Exclusion Criteria:
- major vessels infiltration
- severe organ dysfunction
- refusing laparoscopic approach
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Laparoscopic Distal Pancreatectomy
|
Laparoscopic distal pancreatectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Conversion to open surgery
Time Frame: during surgery; 3 to 5 hours from the start of the procedure
|
during surgery; 3 to 5 hours from the start of the procedure
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Operative Time
Time Frame: during surgery; 3 to 5 hours from the start of the procedure
|
during surgery; 3 to 5 hours from the start of the procedure
|
|
Blood loss
Time Frame: during surgery; 3 to 5 hours from the start of the procedure
|
during surgery; 3 to 5 hours from the start of the procedure
|
|
Length of Hospital Stay
Time Frame: Postoperative. From 0 to 30 days after discharge.
|
Postoperative. From 0 to 30 days after discharge.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2009
Primary Completion (Actual)
August 1, 2010
Study Completion (Actual)
August 1, 2010
Study Registration Dates
First Submitted
December 10, 2010
First Submitted That Met QC Criteria
December 10, 2010
First Posted (Estimate)
December 13, 2010
Study Record Updates
Last Update Posted (Estimate)
December 13, 2010
Last Update Submitted That Met QC Criteria
December 10, 2010
Last Verified
August 1, 2010
More Information
Terms related to this study
Other Study ID Numbers
- PANCREAS-LDP2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Lesions Located at Body or Tail.
-
Assiut UniversityNot yet recruitingCT Scan | EUS Guided Biopsy | Pancreatic Lesions Located at the Body or the Tail
-
ARTIDIS AGH. Lee Moffitt Cancer Center and Research InstituteRecruitingPancreatic Neoplasms | Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma (PDAC) | Pancreatic Lesions Located at the Body or the TailUnited States
-
Tongji HospitalCompletedResectable Lesions Located in the Pancreatic Head or Periampullary Region
-
Wakayama Medical UniversityRecruitingResectable Pancreatic Body/Tail CarcinomaJapan
-
University Hospital, MontpellierRennes University Hospital, Rennes, France; Morgagni Pierantoni Hospital; San... and other collaboratorsCompletedPDAC of the Body and the Tail of the Pancreas | CR- POPFFrance
-
Texas Tech University Health Sciences Center, El...CompletedPancreatic or Peripancreatic Lesions | Lesions in the Esophagus, Stomach, Duodenum or Rectum | Mediastinal ( Chest) Masses | Enlarged Lymph NodesUnited States
-
Wakayama Medical UniversityUnknownDisease of Pancreatic Head or Periampullary Lesions to Require PancreaticoduodenectomyTaiwan
-
Hospital St. Joseph, Marseille, FranceUnknownBiliary Tract Diseases | Common Bile Duct Diseases | Pancreatic Duct Disorder | Lesions of Biliary or Wirsung DuctsFrance
-
University of ToyamaNational Cancer Center, Korea; Samsung Medical Center; Seoul National University... and other collaboratorsCompletedDisease of Pancreatic or Periampullary LesionsJapan
-
American Society for Gastrointestinal EndoscopyMidwest Biomedical Research FoundationUnknownMediastinal or Intra-abdominal Lymphadenopathy, | Pancreatic Masses, | Left Adrenal Masses, | Gastrointestinal Submucosal Lesions, and | Liver MassesUnited States
Clinical Trials on Laparoscopy
-
Campus Bio-Medico UniversityCompletedBenign Gynecological Pathology
-
Royal Surrey County Hospital NHS Foundation TrustCompletedCholecystitis | Gallstones
-
Catholic University of the Sacred HeartFanfani, Francesco, M.D.; Fagotti, Anna, M.D.Completed
-
Medical University of ViennaRecruitingEndometriosis | Endometriosis-related Pain | Endometriosis PelvicAustria
-
Medical University of ViennaRecruitingOvarian Endometrioma | Ovarian EndometriosisAustria
-
Catholic University of the Sacred HeartFanfani, Francesco, M.D.; Fagotti, Anna, M.D.CompletedUterine Cervical Neoplasms | Laparoscopic Surgical ProceduresItaly
-
University Hospital, GasthuisbergCompletedInfertility | EndometriosisBelgium
-
Sohag UniversityNot yet recruitingPregnancy Related | Acute Abdomen
-
Assiut UniversityNot yet recruiting